Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Tecan Group

Market Cap: CHF 1.7b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Novartis

Market Cap: CHF 238.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

BioNTech

Market Cap: CHF 26.0b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Roche Holding

Market Cap: CHF 280.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Gerresheimer

Market Cap: CHF 625.9m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Roche Holding

Market Cap: CHF 280.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Johnson & Johnson

Market Cap: CHF 591.1b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$19.9b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Siegfried Holding

Market Cap: CHF 3.5b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Eli Lilly

Market Cap: CHF 896.5b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Novartis

Market Cap: CHF 238.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 366.3m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Jazz Pharmaceuticals

Market Cap: CHF 7.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Merck KGaA

Market Cap: CHF 46.4b

Operates as a science and technology company in Germany and internationally.

Merck

Market Cap: US$297.4b

Operates as a healthcare company worldwide.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Illumina

Market Cap: CHF 20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Pfizer

Market Cap: CHF 151.4b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Viatris

Market Cap: CHF 16.9b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Evotec

Market Cap: CHF 968.9m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Bristol-Myers Squibb

Market Cap: CHF 126.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Novavax

Market Cap: CHF 1.6b

A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.

Bayer

Market Cap: CHF 37.1b

Operates as a life science company worldwide.

AstraZeneca

Market Cap: CHF 229.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

PolyPeptide Group

Market Cap: CHF 819.8m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

Merck

Market Cap: US$297.4b

Operates as a healthcare company worldwide.

Sandoz Group

Market Cap: CHF 28.0b

Develops, manufactures, and markets generic and biosimilars worldwide.

CRISPR Therapeutics

Market Cap: CHF 5.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Gilead Sciences

Market Cap: CHF 184.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Basilea Pharmaceutica

Market Cap: CHF 645.3m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Cosmo Pharmaceuticals

Market Cap: CHF 1.7b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Santhera Pharmaceuticals Holding

Market Cap: CHF 226.2m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Biogen

Market Cap: CHF 27.6b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

CSL

Market Cap: CHF 101.7b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.